As of Jul 22
| +0.36 / +4.21%|
The 2 analysts offering 12-month price forecasts for Enzymotec Ltd have a median target of 8.50, with a high estimate of 9.00 and a low estimate of 8.00. The median estimate represents a -4.60% decrease from the last price of 8.91.
The current consensus among 3 polled investment analysts is to Buy stock in Enzymotec Ltd. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.